Samuel Deutsch

Executive Vice President, Research and Early Development at Nutcracker Therapeutics, Inc. - Oakland, CA, US

Samuel Deutsch's Contact Details
HQ
N/A
Location
San Francisco,California,United States
Company
Nutcracker Therapeutics, Inc.
Samuel Deutsch's Company Details
Nutcracker Therapeutics, Inc. logo, Nutcracker Therapeutics, Inc. contact details

Nutcracker Therapeutics, Inc.

Oakland, CA, US • 100 - 249 Employees
BioTech/Drugs

Nutcracker Therapeutics is an early stage biotech disrupter founded to develop mRNA-based therapeutic drug products which will be manufactured on our novel ACORN (Automation COntroled RNA) microfluidic based manufacturing system. ACORN is a fully automated, software-controlled microfluidics platform. Our advanced technology-driven approach to therapeutics manufacturing addresses significant challenges associated with production and scale-up of therapeutic products. Automation and microfluidics deliver significantly reduced production cycle times, increased process control, efficiency and reproducibility while greatly reducing manual manipulations, risks of contamination and costly facilities. Through the introduction of breakthrough therapeutic micro factories, Nutcracker is poised to deliver on our mission to significantly improve patient's lives.

N/A
Details about Nutcracker Therapeutics, Inc.
Frequently Asked Questions about Samuel Deutsch
Samuel Deutsch currently works for Nutcracker Therapeutics.
Samuel Deutsch's role at Nutcracker Therapeutics is Executive Vice President, Research and Early Development.
Samuel Deutsch's email address is ***@nutcrackerx.com. To view Samuel Deutsch's full email address, please signup to ConnectPlex.
Samuel Deutsch works in the Research industry.
Samuel Deutsch's colleagues at Nutcracker Therapeutics, Inc. are Srinivas Bandi, Armando Hernandez, Ashley Albiani, Edward Lemmens, Robyn Beckwith, Nicole Peck, Samir Varma and others.
Samuel Deutsch's phone number is N/A
See more information about Samuel Deutsch